Efficacy of moxibustion for pre- or stage I hypertension: Study protocol for a pilot randomized controlled trial

Trials

Volumn 13, Issue , 2012, Pages

  Shin, Kyung Min ^a   Park, Ji Eun ^a   Liu, Yan ^a,b   Jung, Hee Jung ^a   Jung, So Young ^a   Lee, Min Hee ^a   Kang, Kyung Won ^a   Yook, Tae Han ^c   Choi, Sun Mi ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

Hypertension; Moxibustion; Prehypertension

Indexed keywords

ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET; EXERCISE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; INFORMED CONSENT; LIFESTYLE; LIPID ANALYSIS; MOXIBUSTION; PILOT STUDY; PREHYPERTENSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MOXIBUSTION; PILOT PROJECTS; PREHYPERTENSION; QUESTIONNAIRES; REPUBLIC OF KOREA; RESEARCH DESIGN;

EID: 84867049476     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-188     Document Type: Article

References (25)

1. Kannel WB. Blood pressure as a cardiovascular risk factor. J Am Med Assoc 1996, 275(20):1571-1576.
2. Mosca L, Manson JAE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation 1997, 96(7):2468-2482. 10.1161/01.CIR.96.7.2468, 9337227.
3. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. N Eng J Med 1972, 287(16):781-787.
4. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365(9455):217-223.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42(6):1206-1252. 10.1161/01.HYP.0000107251.49515.c2, 14656957.
6. Qureshi AI, Suri MFK, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases?. Stroke 2005, 36(9):1859-1863. 10.1161/01.STR.0000177495.45580.f1, 16081866.
7. Liszka HA, Mainous AG, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005, 3(4):294-299. 10.1370/afm.312, 1466908, 16046560.
8. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu LL, LaCroix AZ, Black HR. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007, 115(7):855-860. 10.1161/CIRCULATIONAHA.106.656850, 17309936.
9. Dong H, Zhang X. An overview of traditional Chinese medicine. Traditional Medicine in Asia. 2002, 17-30. New Delhi: World Health Organisation, Regional Office South -East Asia, Chaudhary RR, Rafei UM.
10. Okazaki M, Aizawa S, Yamauchi M, Oguchi K. Effects of single moxibustion on cutaneous blood vessel and microvascular permeability in mice. Am J Chin Med 1990, 18(3-4):121-130.
11. Kim JI, Choi JY, Lee HS, Lee MS, Ernst E. Moxibustion for hypertension: a systematic review. BMC Cardiovasc Disord 2010, 10(1):33. 10.1186/1471-2261-10-33, 2912786, 20602794.
12. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals. Circulation 2005, 111(5):697-716. 10.1161/01.CIR.0000154900.76284.F6, 15699287.
13. Johanson GA, Brooks GP. Initial scale development: sample size for pilot studies. Educ Psychol Meas 2010, 70(3):394-400.
14. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 2005, 4(4):287-291.
15. Lee BH, Kim CH, Seo JC, Youn HM, Jang KJ, Song CH, Ahn CB. The effects of decreasement of blood pressure on hypertension patients by moxibustion. The Jouranl of Korean Acupuncture and Moxibustion Medicine Society 2001, 18(5):70-76.
16. Liu Y, Park JE, Kim AR, Jung HJ, Choi SM. Review of moxibustion treatment for hypertension in clinical trials. The Jouranl of Korean Acupuncture and Moxibustion Medicine Society 2011, 28(5):87-96.
17. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease?: The Framingham Heart Study. Circulation 1999, 100(4):354-360. 10.1161/01.CIR.100.4.354, 10421594.
18. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001, 103(13):1813-1818. 10.1161/01.CIR.103.13.1813, 11282915.
19. Vernon H, Mior S. The Neck Disability Index: a study of reliability and validity. J Manipulative Physiol Ther 1991, 14(7):409-415.
20. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997, 36(5):551-559. 10.1093/rheumatology/36.5.551, 9189057.
21. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976, 33(6):766-771. 10.1001/archpsyc.1976.01770060086012, 938196.
22. Choi SM, Kang TY, Woo JM. Development and validation of a modified form of the stress response inventory for workers. Journal of Korean Neuropsychiatric Association 2006, 45(6):541-553.
23. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28(2):193-213. 10.1016/0165-1781(89)90047-4, 2748771.
24. Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep 2008, 31(11):1601-1607. 2579971, 19014080.
25. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46(10):1121-1123. 10.1001/archneur.1989.00520460115022, 2803071.